Tags: EU | Germany | Teva | Ratiopharm

Teva to Buy German Generic Drug Maker for $5 Billion

Thursday, 18 Mar 2010 08:05 AM

 

Israeli drug maker Teva says it has beat out other rivals to acquire German generic drug maker Ratiopharm GmbH in a deal worth euro3.6 billion ($4.95 billion).

Teva Pharmaceutical Industries Ltd.'s successful bid gives it a key position in the lucrative German generic market and is the second big acquisition in two years for the company.

The deal, announced Thursday, is subject to regulatory approvals, but is expected to be complete by the end of the year.

Ratiopharm has been up for sale since June.

© Copyright 2015 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Google Clears Translator Tool of Slurs Against Gays

Wednesday, 28 Jan 2015 11:21 AM

Internet search engine giant Google came under fire from the gay community for its translator tool's inclusion of insult . . .

Scientists Discover Faraway Ringed Planet

Wednesday, 28 Jan 2015 10:05 AM

Astronomers said Wednesday they had found the first-ever ringed planet beyond our Solar System, a super-world with a gir . . .

Google's Waze App Endangers Police: LAPD Chief

Wednesday, 28 Jan 2015 07:26 AM

Google's newly acquired Waze application poses a danger to police because of its ability to track their locations, the L . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved